Phaseline

Targets › ACTHLY

ACTHLY: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Metabolic and endocrine.

Open in Phaseline: the race on ACTHLY, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Crinetics PharmaceuticalsCRN04894
ACTH receptor antagonist
ACTHLYPhase 1Cushing Syndrome–

Conditions

Cushing Syndrome (1)

Modalities

small molecule (1)

Companies

Crinetics Pharmaceuticals (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.